Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

World J Urol · 2022 · PMC9512722 · PMID 35916904

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the young OS nearly doubled, but did not reach statistical significance probably due to early deaths that can unfortunately not be elucidated due to the retrospective character of this study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.